Beruflich Dokumente
Kultur Dokumente
www.ischemo.org
Abstract
Virulence factors of Escherichia coli are of two main types; those produced on the surface of the cell and those produced within
the cell and then exported to the site of action. Those on the surface include different sorts of fimbriae that have a role in adhesion to
the surface of host cells but may also have additional roles such as tissue invasion, biofilm formation or cytokine induction. The
activities of cell wall components are discussed and several exported virulence factors are described that have anti host cell activities.
Others virulence factors enable the bacteria to grow in an environment of iron restriction.
# 2003 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Keywords: Virulence factors; Fimbriae; Adhesion; Cytotoxicity
1. Introduction
Escherichia coli is by far the most common pathogen
isolated from urinary tract infections (UTI), and frequently originates from the patients own intestinal
flora. However, only some members of the normal flora
elicit an infection in persons without local or general
predisposing conditions to UTI. E. coli clones present in
the large intestine are not equally able to initiate and
maintain the infectious process in the urinary tract.
Special components or products, called virulence factors, enable E. coli cells to colonise selectively the
mucosal uro-epithelium, evoke an inflammatory reaction and eventually proceed from the lower urinary tract
to the renal cavities and tissues.
0924-8579/03/$30 # 2003 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
doi:10.1016/S0924-8579(03)00236-X
S30
S31
Table 1
Factors of E. coli involved in urinary tract virulence
Virulence factor
Localisation
Function
Reference
Type 1 fimbriae
Bacterial
surface
Bacterial
surface
Bacterial
surface
Bacterial
surface
Bacterial
surface
Bacterial
surface
Bacterial
surface
Bacterial
surface
Bacterial
surface
Exported
Exported
Exported
Exported
Exported
Exported
Exported
Exported
[1 /5]
[7 /9,14]
[10,14]
[11]
[12 /14]
[15,16]a
[17 /19]
[20,21]
Cytotoxicity, haemolysis
Interference with phagocytosis and apoptosis
Cytotoxicity
Cytotoxicity
Cytotoxicity
Growth under iron restriction
Growth under iron restriction
Growth under iron restriction
[25 /31]
[32,33]b
[34]b
[35]b
[36]b
[37,38]
[37,38]
[39]
P fimbriae
S fimbriae
F1C fimbriae
Thin aggregative fimbriae (curli)
Flagellum
Capsule
Lipopolysaccharide
Outer membrane proteins
a-Haemolysin
Cytotoxic necrotising factor 1
Secreted autotransporter toxin
Cytolethal distending toxin
Cytolysin A
Enterobactin
Aerobactin
Yersiniabactin
a
b
[23,24]
5. Conclusion
Net virulence of individual UPEC strains in a given
infection is determined by the presence and actual
S32
Acknowledgements
This work was supported by grants OTKA T037833
and ETT 086/2001 to L.E.
References
[1] Ofek I, Doyle RJ. Bacterial adhesion to cells and tissues. New
York, London: Chapman and Hall, 1994:513 /61.
[2] Schembri MA, Klemm P. Biofilm formation in a hydrodynamic
environment by novel FimH variants and ramifications for
virulence. Infect Immun 2001;69:1322 /8.
[3] Martinez JJ, Mulvey MA, Schilling JD, et al. Type 1 pilusmediated bacterial invasion of bladder epithelial cells. EMBO J
2000;19:2803 /12.
[4] Oelschlaeger TA, Dobrindt U, Hacker J. Virulence factors of
uropathogens. Curr Opin Urol 2002;12:33 /8.
[5] Sokurenko EV, Courtney HS, Ohman P, et al. FimH family of
type 1 fimbrial adhesins: functional heterogeneity due to minor
sequence variations among fimH genes. J Bact 1994;176:748 /55.
[6] Sokurenko EV, Hasty DL, Dykhuizen DE. Pathoadaptive mutations: gene loss and variation in bacterial pathogens. Trends
Microbiol 1999;7:191 /5.
[7] Leffler H, Svanborg-Eden C. Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human
urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol Lett 1980;8:127 /34.
[8] Hedlund M, Wachtler M, Johansson E, et al. P fimbriae
dependent, LPS independent activation of epithelial cytokine
responses. Mol Microbiol 1999;33:693 /703.
[9] Godally G, Bergsten G, Frendeus B, et al. Innate defences and
resistance to Gram-negative mucosal infection. Adv Exp Med
Biol 2000;485:9 /24.
[10] Marre R, Kreft B, Hacker J. Genetically engineered S and F1C
fimbriae differ in their contribution to adherence of Escherichia
coli to cultured renal tubulus cells. Infect Immun 1990;58:3434 /7.
[11] F1C Fimbriae, Hacker J, Morschhauser JS. In: Klemm P, editor.
Fimbriae, Adhesion, Genetics, Biogenesis, and Vaccines. Boca
Raton: CRC Press, 1994:27 /36.
[12] Collinson SK, Emody L, Trust TJ, Kay WW. Thin aggregative
fimbriae from diarrheagenic Escherichia coli . J Bact
1992;174:4490 /5.
[13] Patri E, Szabo E, Pal T, Emody L. Thin aggregative fimbriae on
urinary Escherichia coli isolates. Adv Exp Med Biol
2000;485:219 /24.
[14] Westerlund B, Korhonen TK. Bacterial proteins binding to the
mammalian extracellulat matrix. Mol Microbiol 1993;9:687 /94.
[15] Harmon RC, Rutherford RL, Wu HM, Collins MS. Monoclonal
anti-body-mediated protection and neutralization of motility in
experimental Proteus mirabilis infection. Infect Immun
1989;57:1936 /41.
[16] Allison C, Emody L, Coleman N, Hughes C. The role of swarm
cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis . J Infect Dis 1994;169:1155 /8.
[17] Horwitz MA, Silverstein SC. Influence of the Escherichia coli
capsule on complement fixation, phagocytosis and killing by
human phagocytes. J Clin Invest 1980;65:82 /94.
[18] Finne J. Occurrence of unique polysialosyl carbohydrate units in
glycoproteins of developing brain. J Biol Chem 1982;257:11966 /
70.
[19] Vann VF, Schmidt MA, Jann B, Jann K. The structure of
capsular polysaccharide (K5 antigen) of urinary tract-infective
Escherichia coli O10:K5:H4. A polymer similar to desulfoheparin. Eur J Biochem 1981;116:359 /64.
[20] Morrison DC, Ryan JL. Endotoxins and disease mechanisms.
Annu Rev Med 1987;38:417 /32.
[21] Brade H, Brade L, Rietschel ET. Structure-activity relationships
of bacterial lipopolysaccharides (endotoxins). Zentralbl Bakteriol
Microbiol Hyg [A] 1988;268:151 /79.
[22] Rietschel ET, Brade H, Holst O, et al. Bacterial endotoxin:
chemical constitution, biological recognition, host response, and
immunological detoxification. Curr Top Microbiol Immunol
1996;216:39 /81.
[23] Wandersman C, Deleplaire P. TolC, an Escherichia coli outer
membrane protein required for hemolysin secretion. Proc Natl
Acad Sci USA 1990;87:4776 /80.
[24] Torres AG, Payne SM. Haem iron-transport system in enteroheamorrhagic Escherichia coli O157:H7. Mol Microbiol
1997;23:825 /33.
[25] Smith HW. The haemolysins of Escherichia coli . J Pathol
Bacteriol 1963;85:197 /211.
[26] Ebrspracher B, Hugo F, Bhakdi S. Quantitative study of the
binding and hemolytic efficiency of Escherichia coli hemolysin.
Infect Immun 1989;57:983 /8.
[27] Welch R. Pore-forming cytolysins of gram-negative bacteria. Mol
Microbiol 1991;5:521 /8.
[28] Keane WF, Welch R, Gekker G, Peterson PK. Mechanism of
Escherichia coli a-hemolysin induced injury to isolated renal
tubular cells. Am J Pathol 1987;126:350 /7.
[29] van den Bosch JF, Emody L, Ketyi I. Virulence of haemolytic
strains of Escherichia coli in various animal models. FEMS
Microbiol Lett 1982;13:427 /30.
[30] Emody L, Batai I, Kerenyi M, et al. Anti-Escherichia coli alphahaemolysin in control and patient sera, Lancet 1982;ii:986.
[31] Emody L, Molnar L, Kellermayer M, et al. Urinary Escherichia
coli infection presenting with jaundice. Scand J Infect Dis
1989;21:579 /82.
[32] Caprioli A, Falbo V, Ruggeri FM, et al. Cytotoxic necrotizing
factor production by hemolytic strains of Escherichia coli causing
extra-intestinal infections. J Clin Microbiol 1987;25:758 /61.
[33] Fiorentini C, Fabbri A, Matarrese P, et al. Hinderance of
apoptosis and phagocytic behaviour: induced by Escherichia coli
cytotoxic necrotizing factor (CNF1): two realted activities in
epithelial cells. Biochem Biophys Res Commun 1997;241:341 /6.
[34] Guyer DG, Radulovic S, Jones FE, Mobley HLT. Sat, the
secreted autotransporter toxin of uropathogenic Escherichia coli ,
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]
S33